-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

501. Hematopoietic Stem and Progenitor Biology: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Anemias, Biological, HSCs, Animal models, bone marrow, cell division, Diseases, Therapies, Genetic Disorders, Biological Processes, DNA damage, immunodeficiency, DNA repair, immune cells, Cell Lineage, Study Population, Clinically relevant, hematopoiesis, transplantation, stem cells
Monday, December 7, 2020: 7:00 AM-3:30 PM

Hojun Li, MD, PhD1,2, Vincent Butty2*, Guinevere Connelly2*, Vivian Morris1*, George Q. Daley, MD, PhD3,4, Jennifer Whangbo, MD, PhD3,5, Edroaldo Lummertz da rocha, PhD6* and Robert Grant Rowe, MD, PhD4

1Boston Children's Hospital, Boston, MA
2Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA
3Harvard Medical School, Boston, MA
4Division of Hematology/Oncology, Stem Cell Program, Boston Children's Hospital, Boston, MA
5Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center, Boston, MA
6Department of Microbiology, Immunology and Parasitology, Federal University of Santa Catarina, Florianopolis, Brazil

Thao Trinh, BS1, James Ropa, BS, MSc, PhD2, Arafat Aljoufi, MD1, Scott Cooper, MS2*, Edward F. Srour, PhD3, Anthony Sinn, BS4* and Hal E. Broxmeyer, PhD2

1Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN
2Department of Microbiology & Immunology, Indiana University School of Medicine, Indianapolis, IN
3Department of Medicine, Indiana University School of Medicine, Indianapolis, IN
4Indiana University School of Medicine, Indianapolis, IN

Sara A. Rubin1,2,3*, Chloé S. Baron, PhD2,3*, Song P. Yang, PhD4*, Aaron McKenna, PhD5* and Leonard I. Zon, MD1,2,6,7

1Program in Immunology, Harvard Medical School, Boston, MA
2Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA
3Harvard Stem Cell Institute, Harvard University, Cambridge, MA
4Boston Children's Hospital, Boston
5Department of Molecular and Systems Biology, Geisel School of Medicine, Dartmouth College, Lebanon, NH
6Harvard Stem Cell Institute, Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA
7Howard Hughes Medical Institute, Boston, MA

Kristbjorn Orri Gudmundsson, PhD1*, Yang Du, PhD1, Nhu Nguyen1*, Kevin Oakley1*, Yufen Han1*, Bjorg Gudmundsdottir2*, Pentao Liu3*, Lino Tessarollo4*, Nancy Jenkins5* and Neal Copeland5*

1Department of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD
2NHLBI, NIH, Bethesda, MD
3School of Biomedical Sciences, The University of Hong Kong, Pokfulam, Hong Kong
4CCR-NCI, Mouse Cancer Genetics Program, Frederick
5The University of Texas MD Anderson Cancer Center, Houston, TX

Kim Vanuytsel, PhD1,2, Carlos Villacorta-Martin, MSc2*, Jonathan Lindstrom-Vautrin2*, Zhe Wang3*, Wilfredo Garcia Beltran, MD4*, Taylor Matte2*, Todd W Dowrey, BS2*, Vannesa Mengze Li3*, Ruben Dries, PhD1,3*, Joshua D Campbell, PhD3*, Anna C Belkina, PhD5*, Alejandro Balazs, PhD4* and George J Murphy, PhD1,2

1Section of Hematology and Medical Oncology, Boston University School of Medicine, Boston, MA
2Center for Regenerative Medicine (CReM), Boston University School of Medicine, Boston, MA
3Division of Computational Biomedicine, Boston University School of Medicine, Boston, MA
4Ragon Institute of MGH, MIT and Harvard, Cambridge, MA
5Department of Pathology, Boston University School of Medicine, Boston, MA

Adedamola Elujoba-Bridenstine, MS1*, Lijian Shao, MD, PhD2*, Katherine Zink2*, Laura Sanchez, PhD2*, Kostandin V. Pajcini, PhD3 and Owen J. Tamplin, PhD4

1Department of Cell and Regenerative Biology, University of Wisconsin-Madison, Madison, WI
2University of Illinois at Chicago, Chicago, IL
3Pharmacology, University of Illinois at Chicago, Chicago, IL
4Cell and Regenerative Biology, University of Wisconsin School of Medicine and Public Health, Madison, WI

Marina Feigenson, PhD1*, Remya Nathan2*, Christopher Materna2*, Alana Gudelsky2*, Evan Lema2*, Claire C Tseng, PhD2*, Ffolliott Fisher2*, Jasbir Seehra2* and Jenn Lachey2*

1Keros Therapeutics, Brighton, MA
2Keros Therapeutics, Lexington, MA

Saul Kushinsky, BS*, Matthew V Puccetti, MD/PhD*, Clare M Adams, PhD* and Christine M Eischen, PhD

Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA

*signifies non-member of ASH